HIV medical care interruption among people living with HIV in Spain, 2004-2020
- PMID: 36939068
- DOI: 10.1097/QAD.0000000000003552
HIV medical care interruption among people living with HIV in Spain, 2004-2020
Abstract
Objective: We estimated the incidence rate of HIV medical care interruption (MCI) and its evolution over a 16-year-period, and identified associated risk factors among HIV-positive individuals from the Cohort of the Spanish AIDS Research Network in 2004-2020.
Design: We included antiretroviral-naive individuals aged at least 18 years at enrolment, recruited between January 1, 2004, and August 30, 2019, and followed-up until November 30, 2020.
Methods: Individuals with any time interval of at least 15 months between two visits were defined as having a MCI. We calculated the incidence rate (IR) of having at least one MCI and used multivariable Poisson regression models to identify associated risk factors.
Results: Of 15 274 individuals, 5481 (35.9%) had at least one MCI. Of those, 2536 (46.3%) returned to HIV care after MCI and 3753 (68.5%) were lost to follow-up at the end of the study period. The incidence rate (IR) of MCI was 7.2/100 person-years (py) [95% confidence interval (CI): 7.0-7.4]. The annual IR gradually decreased from 20.5/100 py (95% CI: 16.4-25.6) in 2004 to 4.9/100 py (95% CI: 4.4-5.5) in 2014, a slight increase was observed between 2015 and 2018, reaching 9.3/100 py (95% CI: 8.6-10.2) in 2019. Risk factors for MCI included younger age, lower educational level, having contracted HIV infection through injecting drug use or heterosexual intercourse, having been born outside of Spain, and CD4 + cell count >200 cell/μl, viral load <100 000 and co-infection with hepatitis C virus at enrolment.
Conclusions: Around a third of individuals had at least one MCI during the follow-up. Identified predictors of MCI can help health workers to target and support most vulnerable individuals.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Althoff KN, Chandran A, Zhang J, Arevalo WM, Gange SJ, Sterling TR, et al. Life-expectancy disparities among adults With HIV in the United States and Canada: the impact of a reduction in drug- and alcohol-related deaths using the lives saved simulation model . Am J Epidemiol 2019; 188:2097–2109.
-
- Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies . Lancet HIV 2017; 4:e349–e356.
-
- Giordano TP, Gifford AL, White AC, Almazor MES, Rabeneck L, Hartman C, et al. Retention in care: a challenge to survival with HIV infection . Clin Infect Dis 2007; 44:1493–1499.
-
- Horberg MA, Hurley LB, Silverberg MJ, Klein DB, Quesenberry CP, Mugavero MJ. Missed office visits and risk of mortality among HIV-infected subjects in a large healthcare system in the United States . AIDS Patient Care STDS 2013; 27:442–449.
-
- Mugavero MJ, Westfall AO, Cole SR, Geng EH, Crane HM, Kitahata MM, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality . Clin Infect Dis 2014; 59:1471–1479.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials